Biodesix, Inc. BDSX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Development Services | $3.26M-9.5% | $3.61M+86.6% | $1.93M-8.8% | $2.12M+29.1% | $1.64M-49.1% | |
| Diagnostic Tests | $22.29M-11.4% | $25.15M+26.8% | $19.84M+10.8% | $17.9M+9.7% | $16.32M-5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Biodesix, Inc. break its business down?
- Biodesix, Inc. (BDSX) reports revenue by product across 2 parts — Development Services and Diagnostic Tests. Each is extracted from the segment footnotes and tracked over time.
- Where does Biodesix, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Biodesix, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
